β-galactoside α2,6-sialyltransferases could induce high HER2 α2,6-sialylation, which promoted the proliferation and invasion of tumor cells through protein kinase B (Akt) and ERK signaling pathways [76]. The gene discussed is AKT1; the disease is neoplasm.